Redwood Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6,657
Closed -$1.82M 126
2018
Q1
$1.82M Buy
+6,657
New +$2.07M 0.13% 112
2015
Q3
Sell
-41,763
Closed -$16.9M 176
2015
Q2
$16.9M Buy
41,763
+7,288
+21% +$2.92M 2.09% 13
2015
Q1
$14.6M Sell
34,475
-8,381
-20% -$3.3M 2.33% 7
2014
Q4
$14.5M Sell
42,856
-17,478
-29% -$5.65M 2.2% 11
2014
Q3
$20M Buy
60,334
+14,489
+32% +$4.78M 2.66% 5
2014
Q2
$14.5M Sell
45,845
-6,288
-12% -$1.89M 1.81% 22
2014
Q1
$15.9M Buy
52,133
+1,481
+3% +$470K 2.29% 11
2013
Q4
$14.2M Buy
+50,652
New +$13.1M 2.12% 16

Other funds holding BIIB

Redwood Investments's BIIB Position: Q2 2018 in Review

Redwood Investments sold out of Biogen (BIIB) in Q2 2018, closing a stake of 6,657 shares — an estimated $1.82M sold.

Redwood Investments first reported a position in BIIB in Q4 2013 and held it in 8 quarters. The position peaked at $20M in Q3 2014. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Redwood Investments reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Redwood Investments sold 6,657 Biogen shares in Q2 2018, an estimated $1.82M.
  • Redwood Investments first reported a position in Biogen in Q4 2013 and held it in 8 quarters.
  • Redwood Investments's Biogen position peaked at $20M in Q3 2014.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Redwood Investments's 13F filing for Q2 2018, filed 9 Aug 2018.